34 C
Vientiane
Friday, July 18, 2025
spot_img

Cision PR Newswire

China Pavilion Launches “Zhejiang Week” Event at Expo 2025 Osaka

Immersive Cultural Showcase Highlights the Rich Appeal of Picturesque Zhejiang OSAKA, Japan, July 18, 2025 /PRNewswire/ -- The "Zhejiang Week" celebration at the China Pavilion, Expo 2025 Osaka was officially launched on July 12, 2025, drawing approximately 200 government officials and business leaders from both China and Japan to its...

LEPAS’s First Overseas Showcase: Redefining Premium Mobility at Indonesia Auto Show

JAKARTA, Indonesia, July 18, 2025 /PRNewswire/ -- In April this year, Chery Group officially unveiled...

Beijing Review: Where dynasties meet daily life: China-U.S. Youth explore Xi’an’s living history

BEIJING, July 17, 2025 /PRNewswire/ -- On July 12, the Across the Pacific: China-U.S. Youth...

China Mobile International Launches SJC2 to Enable Seamless Connectivity Across Asia-Pacific

HONG KONG, July 18, 2025 /PRNewswire/ -- China Mobile International Limited (CMI) officially activated...

ACI, a major American optoelectronics company, announces the formation of the ACI_DEFENSE alliance with RC ANLS

ACI_Defence Solution to Serve the Smart City in Thailand BANGKOK, July 18, 2025...

ATFX Appoints Mohammad Aladham as Managing Director for Southeast Asia to Drive Regional Growth

HONG KONG, March 6, 2025 /PRNewswire/ -- ATFX, a global leader in online trading, proudly announces the appointment of Mohammad Aladham as the new...

GenAssist Ltd Announces FDA Clearance of Investigational New Drug Application for GEN6050X, a Globally First-in-Class Base Editing Drug for Duchenne Muscular Dystrophy

SUZHOU, China, March 6, 2025 /PRNewswire/ -- On March 06, 2025, GenAssist Ltd (GenAssist), a pioneering gene-editing biotechnology company specializing in genome medicines, is...

Autoliv Capital Markets Day New Date: June 4, 2025

STOCKHOLM, March 6, 2025 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) and (SSE: ALIV.sdb), the worldwide leader in automotive safety systems, invites financial analysts, institutional investors, and journalists to...

Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed Personalized mRNA Cancer Vaccine

The first patient has been dosed with EVM16 at Peking University Cancer Hospital, marking a major milestone as Everest's proprietary AI-based...